Open Insulin
15 views
Skip to first unread message
Eluemuno Blyden
Oct 27, 2024, 3:33:00 AM10/27/24
to Nicole Vega-Cotto, CCL Open Insulin project
Eluemuno R. Blyden, Ph.D. Cantab.
Founder/ CEO
Mob: +1 510-833-4755
Tel: +1 415-735-5846
AVRIL BIOPHARMA, INC.
This email and all attachments is intended solely for the use of the individual to whom it is addressed and may contain information that is privileged, confidential or otherwise exempt from disclosure under applicable law. If the reader of this email is not the intended recipient or the employee or agent responsible for delivering the message to the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error or are not sure whether it is privileged, please immediately notify us by return e-mail and destroy any copies--electronic, paper or otherwise--which you may have of this communication.
Eluemuno Blyden
Oct 28, 2024, 5:48:31 PM10/28/24
to Nicole Vega-Cotto, CCL Open Insulin project
Glad you liked it!
On Mon, Oct 28, 2024 at 2:55 PM Nicole Vega-Cotto <Nicole.V...@evotec.com> wrote:
Hi Eluem,
Thanks for sending the link for the Open Insulin Project. What an exciting, meaningful, and life-changing initiative. I will take a more thorough look later today to learn more about this wonderful initiative and what they do.
Best regards,
Nicole
Nicole Vega-Cotto, Ph.D. [she/her]
Business Development Manager
+1-609-899-3932 (Mobile)
Evotec (US), Inc. (Headquarters US)
303B College Road East
Princeton, NJ 08540 (USA)
Upcoming OOO: November 7th – 11th
Reply all
Reply to author
Forward
0 new messages